NeuroOne files prospectus supplement for up to $6.75M ATM offering via JonesTrading

NEUROONE MEDICAL TECHNOLOGIES Corp

Filed updated Prospectus Supplement on Aug 15, 2025 for up to $6.75M of common stock via ATM.
Offering made under existing Capital on Demand Sales Agreement with JonesTrading (Dec 2022).
Legal opinion on shares attached as Exhibit 5.1; proceeds not specified.

item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.